RUNX2 and breast cancer: Our study showed that in breast cancer cells NGR1 inhibits the RUNX2 AGE signaling pathway, induces Fe2+ accumulation, enhances intracellular oxidative damage, and thus induces ferroptosis slowing down breast cancer cell proliferation.